RAPT Therapeutics has commenced a Phase 2a clinical trial to assess RPT193, an oral, once-daily monotherapy, for treating moderate-to-severe asthma.

JSS Science and Technology University (JSSSTU) and IN-SPACe have partnered to launch the JNANAM satellite project for medical applications.

British genetics experts emphasize the critical need for a centralized genomic database to connect rare disease patients with clinical trials, particularly benefiting conditions affecting as few as 20 people nationwide.

Researchers are developing a handheld device that uses magnetic pulses to treat chronic insomnia by targeting the default mode network (DMN).

Researchers at the University of Miami Miller School of Medicine are investigating cooling devices to prevent hearing loss in two NIH-funded clinical trials.

The I CAN DO Surgical ACP trial has updated its ethics and regulatory documentation as it transitions to the implementation phase.

AbbVie's final analysis of the phase III MIRASOL trial confirms Elahere (mirvetuximab soravtansine) provides superior efficacy compared to chemotherapy in folate receptor alpha-positive platinum-resistant ovarian cancer patients.

Phase II NERO study demonstrates GSK's Zejula (niraparib) reduced risk of disease progression or death by 27% in relapsed mesothelioma patients compared to standard care.

PhotoPharmics has enrolled 150 participants in its Light for PD Phase 3 clinical trial, evaluating specialized phototherapy for both motor and non-motor symptoms of Parkinson's disease.

The University of Queensland is launching a clinical trial of a novel blood test that has shown 94% accuracy in detecting early-stage ovarian cancer, potentially revolutionizing screening for this deadly disease.

University of Nottingham initiates groundbreaking TrueBlue trial using AI and virtual avatar technology to detect early-stage postnatal depression, offering a modern alternative to traditional clinical scales.

Researchers at University of Illinois have developed drug-carrying DNA aptamers that specifically target leukemia stem cells with a dual mechanism of action, reducing cancer relapse risk.

The Chinese University of Hong Kong's Faculty of Medicine has received Asia's first Histotripsy 2.0 system, a donation from the Li Ka Shing Foundation, aimed at treating liver tumours. This advanced system, set to serve patients by early 2025, offers more precise focal therapy and supports continuous upgrades. The Foundation, along with CU Medicine and the Prince of Wales Hospital Charitable Foundation, will sponsor 30 patients to undergo this novel treatment, marking a significant step forward in cancer treatment research.

University of Wisconsin researchers launch first-of-its-kind Phase 0 clinical trial using patient's own enhanced stem cells to treat salivary gland dysfunction in Sjögren's disease.

Research presented at the European Congress on Obesity suggests weight loss injections may reduce obesity-related cancer risk by nearly 50%, potentially through anti-inflammatory mechanisms beyond simple weight reduction.

Columbia University researchers report that ulefnersen, an experimental drug, demonstrated remarkable efficacy in treating FUS-ALS, a rare genetic form of ALS affecting young people.

Merck has begun the Phase 3 Shorespan-007 trial to assess bomedemstat, an oral LSD1 inhibitor, in essential thrombocythemia (ET) patients without prior cytoreductive therapy.

A new clinical trial in Nigeria demonstrates that an AI-enhanced digital stethoscope significantly improves the detection of peripartum cardiomyopathy.

A nationwide clinical trial is assessing the quality of life (QoL) in young Hodgkin lymphoma patients, marking a shift towards accessible and interpretable patient-reported outcomes.

Brain+ has commenced a clinical trial to evaluate BrainBlossom, a next-generation cognitive training technology, for individuals with Mild Cognitive Impairment (MCI).